Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS.
Publication
, Journal Article
Mahadeo, KM; Cole, PD
Published in: Blood
May 6, 2010
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
May 6, 2010
Volume
115
Issue
18
Start / End Page
3852
Location
United States
Related Subject Headings
- Young Adult
- Treatment Outcome
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Immunology
- Humans
- Homoharringtonine
- Harringtonines
- Fusion Proteins, bcr-abl
- Female
- Antineoplastic Agents, Phytogenic
Citation
APA
Chicago
ICMJE
MLA
NLM
Mahadeo, K. M., & Cole, P. D. (2010). Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS. Blood, 115(18), 3852. https://doi.org/10.1182/blood-2010-02-269233
Mahadeo, Kris M., and Peter D. Cole. “Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS.” Blood 115, no. 18 (May 6, 2010): 3852. https://doi.org/10.1182/blood-2010-02-269233.
Mahadeo KM, Cole PD. Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS. Blood. 2010 May 6;115(18):3852.
Mahadeo, Kris M., and Peter D. Cole. “Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS.” Blood, vol. 115, no. 18, May 2010, p. 3852. Pubmed, doi:10.1182/blood-2010-02-269233.
Mahadeo KM, Cole PD. Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS. Blood. 2010 May 6;115(18):3852.
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
May 6, 2010
Volume
115
Issue
18
Start / End Page
3852
Location
United States
Related Subject Headings
- Young Adult
- Treatment Outcome
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Immunology
- Humans
- Homoharringtonine
- Harringtonines
- Fusion Proteins, bcr-abl
- Female
- Antineoplastic Agents, Phytogenic